Alembic Pharmaceuticals earmarks Rs 720 cr capexIllustrative image – not actual.
Alembic Pharmaceuticals has earmarked a capital expenditure of Rs 720 crore for FY19 to complete existing projects and on maintenance.

The company has spent about Rs 600 crore of capex in FY18. It has four projects under execution at present. It is spending Rs 120 crore towards maintenance capex.

The company has six formulation and three API manufacturing facilities. It manufactures general oral solids in Panelav near Vadodara, Gujarat, and is in the process of putting up oncology oral solids and oncology injectable facilities at the same location.

Both the oncology injectable and the general injectable facilities will be ready in FY19. The new oral solid dosage facility in Jarod will be ready in the second half of FY19.

← All latest storiesBack to top →